Abstract
Founded in 1997, Zyvex is the first molecular nanotechnology company. The company's vision is to become the worldwide supplier of tools, products and services that enable adaptable, affordable and molecularly precise manufacturing. Zyvex technology is being used in biomaterials and subcellular characterization, nanomaterial composites for biomedical implants and 3D microsystems for miniature instrumentation. Nanotechnology is pervasive within biological systems, from membranes (tens of nanometers thick) that facilitate molecular trafficking into and within cells, to proteins (just a few nanometers in size) that perform most structural and functional duties of living organisms. It therefore stands to reason that tools to enable exploration and characterization of biological nanosystems and materials to enhance and repair these systems will be required to realize the full potential of nanomedicine.